Terao et al. demonstrated how dysregulated cholesterol metabolism drives macrophage senescence and the development of subretinal drusenoid deposits in mice. LXR/CD38 signaling activated by cholesterol reduces NAD+ availability and promotes macrophage senescence. Senolytic agents targeting NAD+ decline and senescent macrophages are a potential therapeutic option against early AMD.
Related Posts
Environmentally dependent and independent control of 3D cell shape
Using high-throughput light-sheet microscopy, Dent et al. study 3D cancer cell morphogenesis. Environmental cues modulate the opposing roles of non-muscle myosin II (myosin) and microtubules, with varied impacts on RhoGEFs FARP1 and TIAM2. The study underscores the critical interplay between cytoskeletal […]
Neospora caninum, a Protozoan Killing Dogs, “Might Be Key” to “Total Regression of Tumors”
Neosporosis, caused by the intracellular parasite Neospora caninum, presents a significant challenge in veterinary medicine, leading to serious and life-threatening neurological issues in dogs, and costing the industrial cattle industry billions each year. N. caninum does not infect humans, making […]
A fitness landscape instability governs the morphological diversity of tip-growing cells
Ohairwe et al. demonstrate that an intrinsic mechanical instability in the convergent mechanism of “inflationary” cell growth shared by diverse tip-growing cells leads to a bifurcation (branching) of their fitness landscape. This bifurcation strictly constrains natural tip-growing cell shapes.